Diagnosis and Management of Arrhythmias

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 1153

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cardiology, Klinikum Fuerth, Teaching Hospital of Erlangen-Nuernberg University, Fuerth, Germany
Interests: clinical arrhythmology; atrial fibrillation; heart failure; cardiomyopathies; catheter ablation of arrhythmias

E-Mail Website
Guest Editor
Fondazione Toscana Gabriele Monasterio, Pisa, Italy
Interests: sudden death; ventricular tachycardia; ICD; catheter ablation of arrhythmias; channelopathies
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of Cardiology, Klinikum Fuerth, Teaching Hospital of Erlangen-Nuernberg University, Fuerth, Germany
Interests: clinical arrhythmology; atrial fibrillation; heart failure; CIED therapy; catheter ablation of arrhythmias

Special Issue Information

Dear Colleagues,

We are delighted to extend our invitation to you for the Special Issue titled "Diagnosis and Management of Arrhythmias" in Diagnostics. This Special Issue seeks to provide a comprehensive exploration of the latest advancements, challenges, and best practices in the diagnosis and management of cardiac arrhythmias.

Cardiac arrhythmias are a prevalent global health issue, impacting millions of individuals and significantly affecting their quality of life. Furthermore, they pose substantial risks to cardiovascular health. With the rapid advancements in technology and a deeper comprehension of the underlying pathophysiological mechanisms, there has been a surge of interest in enhancing diagnostic methods and refining therapeutic strategies for managing arrhythmias.

This Special Issue aims to address critical aspects of arrhythmia diagnosis and management, encompassing a wide range of topics, including but not limited to the following:

Advances in electrocardiographic techniques for arrhythmia detection and characterization.

Role of imaging modalities such as echocardiography, cardiac magnetic resonance imaging (MRI), and computed tomography (CT) in the evaluation of arrhythmias.

Emerging biomarkers, genetic markers, and other tools for risk stratification and personalized treatment approaches.

Pharmacological interventions, antiarrhythmic drugs, and their efficacy in rhythm control and symptom management.

Catheter ablation techniques, including advances in mapping technologies and ablation strategies for various arrhythmia substrates.

Role of implantable cardiac devices, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT), in the management of arrhythmias.

Multidisciplinary approaches to arrhythmia care, involving collaboration between cardiologists, electrophysiologists, cardiac surgeons, and other allied healthcare professionals.

Digital health technologies for arrhythmia management.

By gathering insights from leading experts and researchers in the field, this Special Issue aims at providing a comprehensive overview of the current state of the art in arrhythmia diagnosis and management. Through the dissemination of research findings, innovative treatment strategies, and clinical practical state-of-the-art guidelines, we aim at facilitating informed decision-making and ultimately improving outcomes for patients with cardiac arrhythmias.

In this Special Issue, original research articles and reviews are both welcome.

We look forward to receiving your contributions.

Dirk Bastian, Martina Nesti and Laura Vitali-Serdoz

Dr. Laura Vitali-Serdoz
Dr. Martina Nesti
Dr. Dirk Bastian
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arrhythmia
  • electrocardiogram (ECG)
  • cardiac implantable devices
  • antiarrhythmic drugs
  • cardiac monitoring
  • implantable loop recorder
  • digital health
  • wearable devices
  • electrophysiology study
  • catheter ablation
  • ventricular tachycardia
  • atrial fibrillation
  • supraventricular tachycardia
  • syncope

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 877 KiB  
Article
Improvements in Cardiopulmonary Exercise Test Results in Atrial Fibrillation Patients After Radiofrequency Ablation in Kazakhstan
by Akmaral Beisenbayeva, Makhabbat Bekbossynova, Abay Bakytzhanuly, Uldana Aleushinova, Feruza Bekmetova, Assel Chinybayeva, Ayan Abdrakhmanov and Altynay Beyembetova
Diagnostics 2024, 14(21), 2355; https://doi.org/10.3390/diagnostics14212355 - 22 Oct 2024
Viewed by 418
Abstract
This prospective study evaluates the impact of radiofrequency ablation (RFA) on cardiorespiratory indicators in patients with long-standing persistent atrial fibrillation admitted to the Heart Center UMC between January 2022 and April 2024 in Astana, Kazakhstan. The study aims to assess the functional cardiac [...] Read more.
This prospective study evaluates the impact of radiofrequency ablation (RFA) on cardiorespiratory indicators in patients with long-standing persistent atrial fibrillation admitted to the Heart Center UMC between January 2022 and April 2024 in Astana, Kazakhstan. The study aims to assess the functional cardiac benefits of RFA. Out of 717 registered atrial fibrillation patients, 104 were examined before and 3 months after ablation, focusing on cardiorespiratory parameters. A before-and-after analysis using linear mixed models was applied to evaluate changes in cardiorespiratory parameters post-RFA. Significant improvements were noted across various measures. VO2 max increased from 11.5 ± 4.4 mL/kg/min to 18.0 ± 4.5 mL/kg/min (p < 0.001). Oxygen uptake improved from 7.2 ± 2.6 mL/beat to 11.0 ± 3.4 mL/beat (p < 0.001). The 6-min walking test distance rose from 306 ± 82 m to 400 ± 48 m (p < 0.001). METs increased from 4.4 ± 1.6 to 8.0 ± 1.3 (p < 0.001). Heart rate at peak exercise decreased from 175.5 ± 18.6 to 147.2 ± 12.3 beats per minute (p < 0.001). NT-proBNP levels decreased from 1357 ± 1182 to 415 ± 339 pg/mL (p < 0.001). Patients with persistent atrial fibrillation undergoing RFA showed functional improvements in CPET indicators such as VO2 max, METs, O2 pulse, heart rate, and the 6-min walking test. Improvements were also seen in Nt-proBNP analysis. These results emphasize the need for longitudinal follow-up to optimize outcomes and minimize medical risks. Full article
(This article belongs to the Special Issue Diagnosis and Management of Arrhythmias)
Show Figures

Figure 1

Review

Jump to: Research

13 pages, 1428 KiB  
Review
Remote Management of Heart Failure in Patients with Implantable Devices
by Luca Santini, Francesco Adamo, Karim Mahfouz, Carlo Colaiaco, Ilaria Finamora, Carmine De Lucia, Nicola Danisi, Stefania Gentile, Claudia Sorrentino, Maria Grazia Romano, Luca Sangiovanni, Alessio Nardini and Fabrizio Ammirati
Diagnostics 2024, 14(22), 2554; https://doi.org/10.3390/diagnostics14222554 - 14 Nov 2024
Viewed by 346
Abstract
Background: Heart failure (HF) is a chronic disease with a steadily increasing prevalence, high mortality, and social and economic costs. Furthermore, every hospitalization for acute HF is associated with worsening prognosis and reduced life expectancy. In order to prevent hospitalizations, it would [...] Read more.
Background: Heart failure (HF) is a chronic disease with a steadily increasing prevalence, high mortality, and social and economic costs. Furthermore, every hospitalization for acute HF is associated with worsening prognosis and reduced life expectancy. In order to prevent hospitalizations, it would be useful to have instruments that can predict them well in advance. Methods: We performed a review on remote monitoring of heart failure through implantable devices. Results: Precise multi-parameter algorithms, available for ICD and CRT-D patients, have been created, which also use artificial intelligence and are able to predict a new heart failure event more than 30 days in advance. There are also implantable pulmonary artery devices that can predict hospitalizations and reduce the impact of heart failure. The proper organization of transmission and alert management is crucial for clinical success in using these tools. Conclusions: The full implementation of remote monitoring of implantable devices, and in particular, the use of new algorithms for the prediction of acute heart failure episodes, represents a huge challenge but also a huge opportunity. Full article
(This article belongs to the Special Issue Diagnosis and Management of Arrhythmias)
Show Figures

Figure 1

Back to TopTop